BioCardia, Inc. (BCDA)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$0$58,000$477,000$1.4M$1.0M$145,000$710,000$625,000$479,000$576,000$904,000$12,000$0
Gross profit$62,000$12,000$0
Research & development$5.0M$4.4M$7.7M$8.8M$8.6M$9.8M$8.6M$8.5M$5.8M$3.3M$1.5M
Operating income−$8.3M−$8.0M−$11.6M−$11.9M−$12.6M−$15.5M−$14.2M−$14.1M−$12.4M−$7.6M−$5.4M$231,000$9,000−$339,000−$618,000−$583,000
EBITDAderived−$8.3M−$7.9M−$11.6M−$11.8M−$12.6M−$15.5M−$14.1M−$14.0M−$12.3M−$7.6M−$5.4M−$618,000$384,000
Net income−$8.2M−$7.9M−$11.6M−$11.9M−$12.6M−$15.0M−$14.7M−$14.0M−$12.3M−$10.3M−$6.7M$234,000$19,000$305,000$9.7M−$11.5M
Basic EPSper diluted share-$1.23-$2.90-$8.19-$0.67-$0.75-$1.48-$2.61-$3.28-$2.90-$1.23-$4.29$0.00$0.00$0.00$0.04-$0.05
Diluted EPSper diluted share-$0.75-$1.48-$2.61-$3.28-$2.90-$1.23-$4.29$0.00$0.00$0.00$0.04-$0.05

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys74$2.12M disclosed value
Sells (SEC code S)1$6.5K disclosed value
75 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 23, 2026Form 4STERTZER SIMON HDirectorBuyCommon Stock39.0K$1.00$39.0K166.3K
Jun 22, 2026Form 4STERTZER SIMON HDirectorBuyCommon Stock70.2K$0.92$64.6K127.3K
Jun 18, 2026Form 4Altman PeterPresident and CEOBuyCommon Stock800$0.96$768.00300.6K
Jun 17, 2026Form 4Altman PeterPresident and CEOBuyCommon Stock1.5K$0.85$1.3K299.8K
Jun 9, 2026Form 4Altman PeterPresident and CEOBuyCommon Stock5.0K$0.85$4.3K298.3K